Jammu And Kashmir Govt To Permit Home Isolatation

Jammu and Kashmir to permit home isolate of asymptomatic Covid-19 patients who have no co-morbidities. The Jammu and Kashmir government on Monday chose to permit home isolate of asymptomatic COVID-19 patients with no comorbidities if they can have a different space for themselves in the house and download the Aarogya Setu application, authorities said.

The decision was taken at a meeting led by Chief Secretary B V R Subrahmanyam to audit COVID-19 relief quantifies in Jammu and Kashmir. It was additionally concluded that four tertiary emergency hospitals in Srinagar and three in Jammu city would now be referral offices for COVID-19.

“So as to accomplish better consistency among the contacts of COVID-19 patients, it has been concluded that the current act of managerial isolate of COVID positive contacts, will be abstained from and the contacts will be allowed home isolate gave they are asymptomatic,” as indicated by an announcement.

This choice has been taken by the government following the approval of Lieutenant governor Girish Chander Murmu to smoothen the procedure of the executives of COVID-19 patients in Jammu and Kashmir.

Keeping in see better administration of COVID-19 patients, the convention will be reexamined and every single asymptomatic patient with no comorbidities and not weak in any case will be permitted to stay under home isolate, on the off chance that they have a different room office at home and have downloaded the Aarogya Setu versatile application on their telephones, the chief secretary said.

He said every such patient will be furnished with a heartbeat oximeter to screen their oxygen immersion levels and on the occasion of drop-in oxygen immersion under 90 percent, they will promptly answer to hospitals. He said a huge battle for observation including Panchayati Raj Establishments will be started to help in recognize suspected COVID-19 cases in rural regions.

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © 2022 DNN All Rights Reserved